Skip to main content
Premium Trial:

Request an Annual Quote

Coda Genomics, Genencor Sign Screening Agreement

NEW YORK (GenomeWeb News) – Synthetic biology company Coda Genomics said yesterday that it has signed a collaborative agreement with biotechnology company Genencor, a division of Danish firm Danisco.
 
Under the agreement, Coda will use its proprietary approach to develop synthetic gene and protein libraries, which will be screened for use in future research programs by Genencor. Financial terms of the agreement were not disclosed.
 
Genencor develops and markets enzyme and bio-based products for industrial biotechnology, while Coda applies synthetic technologies to create new genes, proteins, and organisms for bioindustrial and life sciences applications.

The Scan

Panel Recommends Pfizer-BioNTech Vaccine for Kids

CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old.

Sharing How to Make It

Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times.

Bring it Back In

Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray.

Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases

In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.